SERB Specialty Pharmaceuticals is a leading Pan-European specialty pharmaceutical group providing a reliable supply of prescription medicines to patients suffering from rare and life-threatening diseases globally. Thanks to our successful growth strategy, we have a consistent portfolio of specialty products in Critical Care and Rare Diseases - even though the portfolio was effectively built around antidotes - which still remains our core business. With our extensive lifesaving medicine portfolio, we are a longstanding partner for health authorities, governmental and non-governmental agencies, therapeutic area experts and patient associations, committed to serve each patient need. SERB's strength is also its agility and we multiplied our assets through a significant European manufacturing network in order to ensure a continuous supply, whatever the needs and emergencies. All our collaborators are driven by a shared vision: together we are committed to provide medical countermeasures. We are proud to save lives.